MedPath

Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)

Not Applicable
Completed
Conditions
HIV Infections
Retina
Ocular Physiology
Registration Number
NCT00431548
Lead Sponsor
Medical University of Vienna
Brief Summary

Ocular lesions, including cotton wool spots and retinal hemorrhage, are a common feature of HIV infection and acquired immunodeficiency syndrome (AIDS). The aetiology of these apparently vasoocclusive phenomena in HIV related retinopathy is not well understood. Several hypotheses including infectious damage of the retinal vasculature and altered retinal hemodynamics have been postulated. The latter would be compatible with the theory that the retina of HIV patients is hypoxic. However, direct measurement of oxygen tension in the retina is not possible and indirect methods have to be employed. The study objective was to investigate the reactivity in retinal blood flow to 100% oxygen breathing in patients with HIV.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria

Group 1 (Patients with HIV)

  • Aged between 19 and 70 years, male and female
  • HIV positive patients without HIV-related retinopathy with a CD4+ cell count  500 cells/mm3 stage A2, A3, B2, B3, C2 and C3.
  • Best corrected visual acuity >= 0.8
  • Ametropy < 6 dpt

Group 2 (Healthy control subjects)

  • Aged between 19 and 70 years
  • Age and sex matched to the subjects in the HIV group (group matched)
  • Matched with regard to the smoking habits in the HIV group
  • Best corrected visual acuity >= 0.8
  • Ametropy < 6 dpt
Exclusion Criteria
  • Evidence of any other eye disease
  • Diabetes mellitus
  • Systemic hypertension (defined as SBP > 150 mmHg or DBP > 90 mmHg)
  • Abuse of illegal drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reactivity in retinal blood flow during 100% O2 breathing expressed as percent change
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Clinical Pharmacology, Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath